AI Terminal
Fresenius Medical Care AG & Co. KGaA
Transaction in Own Shares • Mar 30, 2020
165_rns_2020-03-30_25176363-fe81-4efd-bb83-c620dd85482c.html
Transaction in Own Shares
Open in ViewerOpens in native device viewer
News Details
Other Capital Market Information | 30 March 2020 17:42
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information
Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
30.03.2020 / 17:42
Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
– Share buy-back – 41 st Interim Report
In the period from March 23, 2020 until and including March 27, 2020, a total of 2,985,306 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.
The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):
XETRA
| Day of repurchase | Aggregated volume in number of shares |
Weighted average share price in EUR |
| 23.03.2020 | 354,067 | 55.6526 |
| 24.03.2020 | 423,889 | 56.4566 |
| 25.03.2020 | 484,813 | 55.9871 |
| 26.03.2020 | 499,539 | 57.0763 |
| 27.03.2020 | 511,629 | 57.3918 |
Chi-X Europe
| Day of repurchase | Aggregated volume in number of shares |
Weighted average share price in EUR |
| 23.03.2020 | 83,000 | 55.7166 |
| 24.03.2020 | 85,572 | 56.2945 |
| 25.03.2020 | 90,000 | 55.9076 |
| 26.03.2020 | 94,572 | 57.0598 |
| 27.03.2020 | 99,576 | 57.3779 |
BATS Europe
| Day of repurchase | Aggregated volume in number of shares |
Weighted average share price in EUR |
| 23.03.2020 | 15,481 | 55.5304 |
| 24.03.2020 | 15,382 | 56.3401 |
| 25.03.2020 | 19,890 | 55.8949 |
| 26.03.2020 | 83,072 | 57.1051 |
| 27.03.2020 | 29,996 | 57.3063 |
Turquoise
| Day of repurchase | Aggregated volume in number of shares |
Weighted average share price in EUR |
| 23.03.2020 | 17,634 | 55.5915 |
| 24.03.2020 | 13,783 | 56.3085 |
| 25.03.2020 | 16,470 | 56.0811 |
| 26.03.2020 | 22,000 | 57.0759 |
| 27.03.2020 | 24,941 | 57.3308 |
The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including March 27, 2020 therefore amounts to 8,888,355 shares.
Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.
Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board
Bad Homburg v.d.H., March 30, 2020
30.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Fresenius Medical Care AG & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg | |
| Germany | |
| Internet: | www.freseniusmedicalcare.com |
| End of News | DGAP News Service |